CFB and cardiac hypertrophy: The importance of GRK2 in cardiomyocyte hypertrophy is supported by a recent study from Kamal et al. [34], which reported to abolish cardiac hypertrophy following TAC by treatment with the Gβγ inhibitor Gallein, known to inhibit GRK2 membrane translocation.